Erwin W. Gelfand
About
In The Last Decade
Erwin W. Gelfand
608 papers receiving 26.1k citations
Peers
Comparison fields: 5 of 163
- Immunology 11.8k
- Physiology 9.2k
- Molecular Biology 6.8k
- Pulmonary and Respiratory Medicine 4.5k
- Immunology and Allergy 3.7k
Countries citing papers authored by Erwin W. Gelfand
This map shows the geographic impact of Erwin W. Gelfand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin W. Gelfand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin W. Gelfand more than expected).
Fields of papers citing papers by Erwin W. Gelfand
This network shows the impact of papers produced by Erwin W. Gelfand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin W. Gelfand. The network helps show where Erwin W. Gelfand may publish in the future.
Co-authorship network of co-authors of Erwin W. Gelfand
This figure shows the co-authorship network connecting the top 25 collaborators of Erwin W. Gelfand. A scholar is included among the top collaborators of Erwin W. Gelfand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erwin W. Gelfand. Erwin W. Gelfand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 7 | |
| 3 | 11 | |
| 4 | 36 | |
| 5 | 34 | |
| 6 | 52 | |
| 7 | 94 | |
| 8 | 38 | |
| 9 | 50 | |
| 10 | 40 | |
| 11 | 37 | |
| 12 | 61 | |
| 13 | Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells. | 48 |
| 14 | 38 | |
| 15 | 12 | |
| 16 | Therapeutic interference with interferon-gamma (IFN-gamma) and soluble IL-4 receptor (sIL-4R) in allergic diseases. | 8 |
| 17 | 57 | |
| 18 | 21 | |
| 19 | 12 | |
| 20 | Normal B-lymphocyte function in patients with Lesch-Nyhan syndrome and HGPRT deficiency. | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.